Medical Plastic Extrusion Market Global Report 2026

The medical plastic extrusion market size has grown strongly in recent years. It will grow from $4.97 billion in 2025 to $5.31 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period was driven by increasing demand for disposable medical devices, rising adoption of minimally invasive procedures, growing expansion of healthcare infrastructure, increasing use of plastic components in medical applications, and rising need for cost-effective medical manufacturing solutions.

The medical plastic extrusion market size is expected to see strong growth in the next few years. It will grow to $6.82 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for customized medical extrusion products, rising adoption of advanced biocompatible polymers, growing investments in medical device manufacturing, expanding applications of extrusion technology in diagnostics and patient care, and increasing focus on sustainable medical plastic solutions. Major trends in the forecast period include increasing demand for precision medical plastic extrusion solutions, growing adoption of advanced medical-grade polymer materials, rising production of customized extruded medical components, increasing focus on sterile and high-quality medical plastic manufacturing, and growing demand for minimally invasive medical device components.

The increasing demand for minimally invasive medical procedures is expected to propel the growth of the medical plastic extrusion market going forward. Minimally invasive medical procedures are specialized treatment techniques that use small incisions or natural body pathways to reduce tissue damage, accelerate recovery, and improve patient outcomes. The demand for minimally invasive medical procedures is increasing due to the growing prevalence of chronic diseases and the rising preference for faster recovery, shorter hospital stays, and cost-effective treatment options. Medical plastic extrusion supports minimally invasive medical procedures by enabling the production of high-precision medical tubing, catheter components, multilumen tubing, and microextrusions that are essential for advanced minimally invasive devices requiring flexibility, precision, and consistent performance within the human body. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, cosmetic surgical procedures increased by 5% between 2023 and 2024, reaching a total of 27,462 procedures in 2024. Therefore, the increasing demand for minimally invasive medical procedures is driving the growth of the medical plastic extrusion market.

Major companies operating in the medical plastic extrusion market are focusing on developing advanced extrusion solutions, such as thin-walled etched polytetrafluoroethylene (PTFE) liners, to improve catheter performance, increase device flexibility, and support precise navigation during minimally invasive medical procedures. A thin-wall etched PTFE liner refers to a precision-extruded fluoropolymer tube manufactured with an ultra-thin wall structure and a chemically etched inner surface to reduce friction, enhance lubricity, and facilitate smoother movement of medical devices such as catheters during complex interventional procedures. For instance, in October 2025, Junkosha, a Japan-based medical polymer and advanced materials company, introduced an ultra-thin wall etched polytetrafluoroethylene (PTFE) liner featuring greater flexibility, enhanced lubricity through a chemically etched inner lumen surface, and high dimensional precision. The innovation is designed to improve catheter performance and enable smoother device navigation in cardiovascular and neurovascular minimally invasive procedures.

In July 2025, Arterex, a US-based provider of medical device development and advanced assembly solutions for the medical device and life sciences industries, acquired Xponent Global, Inc. for an undisclosed amount. Through this acquisition, Arterex expanded its medical extrusion capabilities across North America, strengthening its ability to deliver localized high-precision extrusion solutions while enhancing its manufacturing portfolio for medical device customers. Xponent Global, Inc. is a US-based, ISO 9001:2015-certified manufacturer of extruded tubing for the medical industry.

Major companies operating in the medical plastic extrusion market are Integer Holdings Corporation, Saint-Gobain S.A., Nordson Corporation, Teleflex Incorporated, Putnam Plastics, MicroLumen Inc., Medical Murray Inc., Microspec Corporation, Optinova Holding AB Ltd., Teel Plastics Inc., A.P. Extrusion Inc., RAUMEDIC AG.

North America was the dominating region in the medical plastic extrusion market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical plastic extrusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical plastic extrusion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.